News From PHASE Scientific
Stay up-to-date on company & product news, government, and business trends.
Phase Scientific donates 600 of its INDICAID® COVID-19 Rapid Antigen At-Home Tests for CancerCon in Minneapolis June 9-12
PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that it has donated 600 of its approved INDICAID® COVID-19 2-pack Rapid Antigen At-Home Test (INDICAID® OTC) to Stupid Cancer, Inc., a 501(c)3 nonprofit leader in the adolescent and young adult cancer movement […]
INDICAID® COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)
Updated May 24TH, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.
An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that […]
PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests
INDICAID® OTC COVID-19 Rapid Antigen Tests Now Available for Direct Consumer Purchase
GARDEN GROVE, CA, April 25, 2022 — PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) is now […]
INDICAID® OTC COVID-19 Rapid Antigen At-Home Test Receives FDA EUA
PHASE Scientific’s COVID-19 Rapid Antigen At-Home Test Now Available Across the U.S.—Enabling the American Public to Perform the Test On-Demand
GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ — PHASE Scientific International, LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its INDICAID® COVID-19 […]
Hong Kong’s Hospitals Reach a Breaking Point as Infections Skyrocket
Will Antiviral Drugs Make Significant Impact?
As PHASE Scientific USA continues to monitor the pandemic on a global scale, the spotlight has fallen on Hong Kong, where the count of daily COVID-19 cases has reached upwards of 4,000 for the very first time.
The steep surge of cases […]
Performance of the INDICAID® COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)
The B.1.1.529 variant, termed the Omicron variant, is a highly transmissible SARS-CoV-2 variant of concern. It is important that current SARS-CoV-2 diagnostic tests remain capable of detecting the B.1.1.529 variant. This white paper describes our evaluation of the INDICAID® COVID-19 Rapid Antigen Test when used to detect specimens […]